Osseous Complications of Renal Transplantation

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Seminars in Dialysis

• Publication date

  1996-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1525-139X.1996.tb00697.x
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Aseptic necrosis of bone following renal transplantation. Clinical and biochemical aspects and bone morphometry.

  2009cited by this paper
• Acute oral calcium load decreases parathyroid secretion and suppresses tubular phosphate loss in long-term renal transplant recipients.

  1995cited by this paper
• Lack of evidence that cyclosporine treatment impairs calcium-phosphorus homeostasis and bone remodeling in normocalcemic long-term renal transplant recipients.

  1995cited by this paper
• Calcium Metabolism following Renal Transplantation

  1995cited by this paper
• COMPARISON OF POLYMERASE CHAIN REACTION FROM PLASMA AND BUFFY COAT WITH ANTIGEN DETECTION AND OCCURRENCE OF IMMUNOGLOBULIN M FOR THE DEMONSTRATION OF CYTOMEGALOVIRUS INFECTION AFTER LIVER TRANSPLANTATION

  1995cited by this paper
• Treatment of osteonecrosis of the femoral head with free vascularized fibular grafting

  1995cited by this paper
• Prevention of cancellous bone loss but persistence of renal bone disease despite normal 1,25 vitamin D levels two years after kidney transplantation.

  1995cited by this paper
• Anti‐Gal activity In diabetic patients transplanted with fetal porcine Islet cell clusters

  1995cited by this paper
• Bone marrow, cytokines, and bone remodeling

  1995cited by this paper
• Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis.

  1995cited by this paper
• Treatment of osteonecrosis of the femoral head with free vascularized fibular grafting. A long-term follow-up study of one hundred and three hips.

  1995cited by this paper
• Bone mineral density after kidney transplantation. A cross-sectional study in 190 graft recipients up to 20 years after transplantation.

  1995cited by this paper
• Loss of regional bone mineral density in the first 12 months following renal transplantation.

  1994cited by this paper
• Slow-Release Sodium Fluoride in the Management of Postmenopausal Osteoporosis

  1994cited by this paper
• Sequential changes in vitamin D and calcium metabolism after successful renal transplantation.

  1994cited by this paper
• Influence of age on cyclosporin A‐induced alterations in bone mineral metabolism in the rat in vivo

  1994cited by this paper
• FACTORS INFLUENCING VERTEBRAL BONE DENSITY AFTER RENAL TRANSPLANTATION

  1994cited by this paper
• Changes in bone mass early after kidney transplantation

  1994cited by this paper
• Prevention of orthotopic liver allograft rejection in rats with a short-term brequinar sodium therapy. Analysis of intragraft cytokine gene expression.

  1994cited by this paper
• Bone fracture and osteodensitometry with dual energy X-ray absorptiometry in kidney transplant recipients.

  1994cited by this paper
• Trends in the use of glucocorticoids in renal transplantation.

  1994cited by this paper
• ORTHOTOPIC LIVER TRANSPLANTATION IN PATIENTS OVER 60 YEARS OLD

  1994cited by this paper
• Calcium Metabolism following Renal Transplantation

  1994cited by this paper
• Fracture frequency after kidney transplantation.

  1994cited by this paper
• The deleterious effects of long-term cyclosporine A, cyclosporine G, and FK506 on bone mineral metabolism in vivo.

  1994cited by this paper
• TREATMENT OF GROWTH FAILURE IN CHILDREN AFTER RENAL TRANSPLANTATION1

  1993cited by this paper
• EFFECT OF DAILY ORAL VITAMIN D AND CALCIUM THERAPY, HYPOPHOSPHATEMIA, AND ENDOGENOUS 1–25 DIHYDROXYCHOLECALCIFEROL ON PARATHYROID HORMONE AND PHOSPHATE WASTING IN RENAL TRANSPLANT RECIPIENTS

  1993cited by this paper
• Bone loss after organ transplantation

  1993cited by this paper
• Musculoskeletal complications after renal transplantation: pathogenesis and treatment.

  1992cited by this paper
• Nontraumatic necrosis of bone (osteonecrosis).

  1992cited by this paper
• Prednisone-induced osteopenia in beagles: variable effects mediated by differential suppression of bone formation.

  1992cited by this paper
• Rapid loss of vertebral mineral density after renal transplantation.

  1991cited by this paper
• A double-blind study of deflazacort and prednisone in patients with chronic inflammatory disorders.

  1991cited by this paper
• A short course of recombinant human growth hormone treatment stimulates osteoblasts and activates bone remodeling in normal human volunteers

  1990cited by this paper
• Treatment of steroid-induced osteopenia with calcitonin in corticosteroid-dependent asthma. A one-year follow-up study.

  1990cited by this paper
• The Role of Growth Hormone in Modulation of the Immune Response a

  1990cited by this paper
• Human growth hormone prevents the protein catabolic side effects of prednisone in humans.

  1990cited by this paper
• Deflazacort versus 6-methylprednisolone in renal transplantation: immunosuppressive activity and side effects.

  1990cited by this paper
• Combined treatment with cyclosporin A and cortisone acetate minimizes the adverse bone effects of either agent alone

  1990cited by this paper
• STRATEGIES FOR OPTIMIZING GROWTH IN CHILDREN WITH KIDNEY TRANSPLANTS

  1989cited by this paper
• Aseptic necrosis of bone following renal transplantation: relation with hyperparathyroidism.

  1989cited by this paper
• Cyclosporin A in the oophorectomized rat: Unexpected severe bone resorption

  1989cited by this paper
• Tertiary hyperparathyroidism after renal transplantation: operative indications.

  1989cited by this paper
• Total hip replacement in the renal transplant recipient.

  1989cited by this paper
• Aseptic bone necrosis after renal transplantation.

  1988cited by this paper
• Cyclosporin-A in vivo produces severe osteopenia in the rat: effect of dose and duration of administration.

  1988cited by this paper
• Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD).

  1988cited by this paper
• BONE HISTOLOGY IN RENAL TRANSPLANT PATIENTS RECEIVING CYCLOSPORIN

  1988cited by this paper
• Cyclosporin in cadaveric renal transplantation: 5-year follow-up of a multicentre trial.

  1987cited by this paper
• Cyclosporin A and osteonecrosis of the femoral head.

  1987cited by this paper
• Studies of nontraumatic osteonecrosis. The role of core decompression in the treatment of nontraumatic osteonecrosis of the femoral head.

  1987cited by this paper
• Across-study evaluation of association between steroid dose and bolus steroids and avascular necrosis of bone.

  1987cited by this paper
• Reduced phosphate reabsorption unrelated to parathyroid hormone after renal transplantation: implications for the pathogenesis of hyperparathyroidism in chronic renal failure.

  1986cited by this paper
• Cyclosporine a inhibits calcemic hormone‐induced bone resorption in vitro

  1986cited by this paper
• THE DECREASED INCIDENCE OF ASEPTIC NECROSIS IN RENAL TRANSPLANT RECIPIENTS—A CASE CONTROL STUDY

  1986cited by this paper
• Idiopathic bone necrosis of the femoral head. Early diagnosis and treatment.

  1985cited by this paper
• Osteonecrosis and fractures following renal transplantation.

  1985cited by this paper
• Idiopathic bone necrosis of the femoral head. Early diagnosis and treatment.

  1985cited by this paper
• Effect of oral 1,25-dihydroxyvitamin D and calcium on glucocorticoid-induced osteopenia in patients with rheumatic diseases.

  1984cited by this paper
• Calcium metabolism and hyperparathyroidism after renal transplantation.

  1983cited by this paper
• Total hip replacement in patients with renal transplants.

  1983cited by this paper
• Steroid-induced fractures and bone loss in patients with asthma.

  1983cited by this paper
• Hypercalcemic hyperparathyroidism following renal transplantation: differential diagnosis, management, and implications for cell population control in the parathyroid gland.

  1982cited by this paper
• Hypercalcemic hyperparathyroidism following renal transplantation: differential diagnosis, management, and implications for cell population control in the parathyroid gland.

  1982cited by this paper
• The natural history and surgical treatment of hypercalcemia before and after renal transplantation.

  1982cited by this paper
• Decreased phosphate reabsorption after renal transplantation: Evidence for a mechanism independent of calcium and parathyroid hormone.

  1981cited by this paper
• Decreased secondary hyperparathyroidism in diabetic patients receiving hemodialysis.

  1981cited by this paper
• ASEPTIC NECROSIS OF BONE FOLLOWING RENAL TRANSPLANTATION: EXPERIENCE IN 194 TRANSPLANT RECIPIENTS AND REVIEW OF THE LITERATURE

  1978cited by this paper
• Letter: Screening for breast cancer.

  1976cited by this paper
• Fatty fools and obesity.

  1960cited by this paper
• Diseases of the lungs.

  1948cited by this paper

• Bone disease after renal transplantation.

  2003cites this paper
• Tacrolimus and low-dose steroid immunosuppression preserves bone mass after renal transplantation

  2002cites this paper
• Bone mineral density after renal transplantation.

  1998cites this paper